Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-23 4:36 pm Sale | 2021-12-31 | 13G | Artelo Biosciences, Inc. ARTL | Iroquois Capital Management LLC | 6,667 0.240% | -54,667 (-89.13%) | Filing History |
| 2022-02-09 11:08 am Sale | 2021-12-31 | 13G | Artelo Biosciences, Inc. ARTL | Parian Global Management LP | 0 0.000% | -79,983 (Position Closed) | Filing History |
| 2022-02-04 3:19 pm Sale | 2021-12-31 | 13G | Artelo Biosciences, Inc. ARTL | Hudson Bay Capital Management LP | 0 0.000% | -61,333 (Position Closed) | Filing History |
| 2021-03-01 4:38 pm Purchase | 2021-02-22 | 13G | Artelo Biosciences, Inc. ARTL | Parian Global Management LP | 79,983 7.640% | 79,983 (New Position) | Filing History |
| 2021-02-16 09:53 am Sale | 2020-12-31 | 13G | Artelo Biosciences, Inc. ARTL | CVI Investments, Inc. | 52,911 4.900% | -8,422 (-13.73%) | Filing History |
| 2021-02-10 4:12 pm Unchanged | 2020-12-31 | 13G | Artelo Biosciences, Inc. ARTL | BIGGER CAPITAL FUND L P | 60,000 4.990% | 0 (Unchanged) | Filing History |
| 2021-02-08 5:07 pm Purchase | 2020-12-31 | 13G | Artelo Biosciences, Inc. ARTL | Hudson Bay Capital Management LP | 61,333 5.740% | 61,333 (New Position) | Filing History |
| 2021-02-05 4:23 pm Unchanged | 2020-12-31 | 13G | Artelo Biosciences, Inc. ARTL | KINGSBROOK PARTNERS LP | 53,333 4.990% | 0 (Unchanged) | Filing History |
| 2021-01-15 11:30 am Sale | 2020-12-31 | 13G | Artelo Biosciences, Inc. ARTL | ALPHA CAPITAL ANSTALT | 52,267 4.990% | -1,066 (-2.00%) | Filing History |
| 2021-01-13 09:02 am Unchanged | 2020-12-31 | 13G | Artelo Biosciences, Inc. ARTL | Empery Asset Management LP | 61,333 4.990% | 0 (Unchanged) | Filing History |
| 2020-10-26 06:09 am Unchanged | 2020-10-14 | 13G | Artelo Biosciences, Inc. ARTL | Mitchell P. Kopin | 0 0.000% | 0 (Unchanged) | Filing History |
| 2020-10-22 1:18 pm Purchase | 2020-10-14 | 13G | Artelo Biosciences, Inc. ARTL | ALPHA CAPITAL ANSTALT | 53,333 5.290% | 53,333 (New Position) | Filing History |
| 2020-10-19 4:33 pm Purchase | 2020-10-09 | 13G | Artelo Biosciences, Inc. ARTL | BIGGER CAPITAL FUND L P | 60,000 5.800% | 60,000 (New Position) | Filing History |
| 2020-10-19 3:25 pm Purchase | 2020-10-14 | 13G | Artelo Biosciences, Inc. ARTL | Iroquois Capital Management LLC | 61,333 6.670% | 61,333 (New Position) | Filing History |
| 2020-10-15 10:54 am Purchase | 2020-10-09 | 13G | Artelo Biosciences, Inc. ARTL | Empery Asset Management LP | 61,333 6.670% | 61,333 (New Position) | Filing History |
| 2020-10-15 10:17 am Purchase | 2020-10-09 | 13G | Artelo Biosciences, Inc. ARTL | CVI Investments, Inc. | 61,333 6.700% | 61,333 (New Position) | Filing History |
| 2020-10-15 08:45 am Purchase | 2020-10-14 | 13G | Artelo Biosciences, Inc. ARTL | KINGSBROOK PARTNERS LP | 53,333 5.800% | 53,333 (New Position) | Filing History |
| 2020-02-14 4:19 pm Purchase | 2019-12-31 | 13G | Artelo Biosciences, Inc. ARTL | O'Brien Peter Michael | 23,000 10.070% | 23,000 (New Position) | Filing History |
| 2020-02-14 4:18 pm Purchase | 2019-12-31 | 13G | Artelo Biosciences, Inc. ARTL | Moss David J | 16,604 7.270% | 16,604 (New Position) | Filing History |
| 2020-02-14 4:18 pm Purchase | 2019-12-31 | 13G | Artelo Biosciences, Inc. ARTL | Gorgas Gregory D. | 18,676 8.170% | 18,676 (New Position) | Filing History |